Business
RadioMedix gains FDA approval for Ga-68 PSMA-11
The ANDA approval covers gallium Ga 68 gozetotide injection for PET imaging in prostate cancer, alongside FDA inspection of RadioMedix’s SPICA Center.
Company
RadioMedix
Company
The ANDA approval covers gallium Ga 68 gozetotide injection for PET imaging in prostate cancer, alongside FDA inspection of RadioMedix’s SPICA Center.